Ulrike Gnad-Vogt
Chief Tech/Sci/R&D Officer at CureVac SE
Ulrike Gnad-Vogt active positions
Companies | Position | Start | End |
---|---|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Chief Tech/Sci/R&D Officer | 31/12/2010 | - |
Career history of Ulrike Gnad-Vogt
Former positions of Ulrike Gnad-Vogt
Companies | Position | Start | End |
---|---|---|---|
CUREVAC N.V. | Chief Tech/Sci/R&D Officer | 31/12/2010 | 31/12/2018 |
Corporate Officer/Principal | 31/12/2018 | - |
Training of Ulrike Gnad-Vogt
Universität des Saarlandes | Doctorate Degree |
Statistics
International
Germany | 4 |
Operational
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
CUREVAC N.V. | Health Technology |
Private companies | 1 |
---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
- Stock Market
- Insiders
- Ulrike Gnad-Vogt
- Experience